Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGSWW) FCF Margin (2020 - 2025)

GeneDx Holdings has reported FCF Margin over the past 6 years, most recently at 6.15% for Q4 2025.

  • Quarterly results put FCF Margin at 6.15% for Q4 2025, down 555.0% from a year ago — trailing twelve months through Dec 2025 was 3.34% (up 1267.0% YoY), and the annual figure for FY2025 was 3.34%, up 1267.0%.
  • FCF Margin for Q4 2025 was 6.15% at GeneDx Holdings, down from 8.22% in the prior quarter.
  • Over the last five years, FCF Margin for WGSWW hit a ceiling of 8.22% in Q3 2025 and a floor of 242.54% in Q2 2022.
  • Median FCF Margin over the past 5 years was 62.98% (2021), compared with a mean of 69.32%.
  • Biggest five-year swings in FCF Margin: plummeted -18414bps in 2022 and later soared 12923bps in 2023.
  • GeneDx Holdings' FCF Margin stood at 105.87% in 2021, then rose by 8bps to 97.25% in 2022, then surged by 48bps to 50.11% in 2023, then surged by 99bps to 0.6% in 2024, then tumbled by -930bps to 6.15% in 2025.
  • The last three reported values for FCF Margin were 6.15% (Q4 2025), 8.22% (Q3 2025), and 7.84% (Q2 2025) per Business Quant data.